drugset / Trial / NCT03193216

The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus

NCT03193216

Phase 2 Completed 24 enrolled Medical University of South Carolina
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the addition of an alginate based solution to twice daily proton pump inhibitor therapy (PPI) in patients undergoing ablative therapy for dysplastic Barrett's esophagus. The investigators hypothesize that the addition of this medication will help to achieve complete remission of Barrett's over a shorter period of time.

Timeline

Start
2017-08-25
Primary completion
2022-01-01
Completion
2022-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Alginic acid Other / unclassified 10 ml

Indications